Cancer
Cancer immunotherapy has shown significant promise in the treatment of various cancers, but a new study highlights a growing concern: the risk of venous thromboembolism (VTE). According to investigators at Emory University, the incidence of VTE in patients receiving immunotherapies for cancer is a significant complication, with distinct pathophysiological mechanisms
Cancer
A team of researchers from the University Grenoble-Alpes has made significant advancements in the field of biotechnology, particularly in cancer gene therapy. Their study, published in the European Journal of Pharmaceutical Sciences, explores the potential of photodynamic drug delivery systems in cancer treatment. The researchers propose a novel approach using
Cancer
Researchers at Central South University have published a comprehensive review on the mechanisms of immune evasion in cancer and potential therapeutic approaches. The review highlights the complex processes by which tumors evade immune surveillance, including tumor-induced immune suppression, immune checkpoint regulation, and genetic and epigenetic influences. The study also emphasizes
Cancer
Genprex, a clinical-stage gene therapy company, has been granted patents for its lead drug candidate, Reqorsa, in combination with PD-L1 and PD-1 antibodies by the U.S. Patent and Trademark Office and the European Patent Office. These patents will expire in 2037 at the earliest, providing Genprex with intellectual property
Cancer
Researchers at Mass General Brigham have found that cases of HPV-associated throat cancer have increased by over 200% in the US, projected to continue increasing for the next 10 years. While the number of cervical cancer cases has been decreasing due to the HPV vaccine and effective screening methods, throat
Cancer
InhaleRx Ltd. has registered a Phase 2 clinical trial with the Australian New Zealand Clinical Trials Registry (ANZCTR) to investigate the efficacy and safety of IRX211a for the treatment of breakthrough cancer pain in opioid-tolerant patients. The study aims to determine whether IRX211a can provide fast and effective pain relief
Cancer
Chris Evert, the 18-time Grand Slam winner, has been a beacon of hope and inspiration for millions of people around the world. In the last five years, she has faced her biggest challenge: battling cancer twice. Her remarkable journey is a testament to her strength, humility, and compassion. Evert'
Cancer
A clinical trial led by Dr. Michael Wong, a physician at Roswell Park Comprehensive Cancer Center, has shown promising results in treating advanced melanoma with a combination of RP1, an oncolytic virus, and nivolumab (Opdivo), an immunotherapy medication. The study, published in the Journal of Clinical Oncology, found that the
Cancer
Genprex, Inc. has announced that it has received a Notice of Allowance for a patent covering the use of its lead drug candidate, Reqorsa Gene Therapy, in combination with PD-L1 antibodies, such as Tecentriq. This patent will expire in 2037 at the earliest. The company has also been granted patents
Cancer
Two determined cyclists, Andrew Leverton and Craig Pickles, completed an incredible 470-mile bike ride from Blackpool Tower to the Eiffel Tower in just three days to raise money for the Chemotherapy Unit at Burnley General Teaching Hospital. The ride was inspired by their friend Trevor Kegg, who was diagnosed with
Cancer
Cancer has gone from a death sentence to a manageable, sometimes preventable, disease. According to the World Health Organization (WHO), the age-adjusted cancer death rate in the US declined by one-third between 1991 and 2021, saving more than four million lives. Meanwhile, the number of people dying from cancer doubled
Cancer
The Philippine Cancer Society (PCS) has ramped up its efforts to bring life-saving cancer screening services to more underserved communities across the country through its flagship ACT NOW (Access to Cancer Treatment Now) campaign. The expanded program will include artificial intelligence-assisted screening for liver and lung cancer, in addition to
